Budesonide-incorporated inhalable lipid nanoparticles for antiTSLP nanobody mRNA delivery to treat steroid-resistant asthma

Authors: Huang, J., Bai, X., Stewart, W. et al

Journal: Nat Commun 16

Year: 2025

📄 View PDF

← Back to Publications